1. Home
  2. FLGT vs MCB Comparison

FLGT vs MCB Comparison

Compare FLGT & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • MCB
  • Stock Information
  • Founded
  • FLGT 2011
  • MCB 1999
  • Country
  • FLGT United States
  • MCB United States
  • Employees
  • FLGT N/A
  • MCB 293
  • Industry
  • FLGT Medical Specialities
  • MCB Major Banks
  • Sector
  • FLGT Health Care
  • MCB Finance
  • Exchange
  • FLGT Nasdaq
  • MCB Nasdaq
  • Market Cap
  • FLGT 697.3M
  • MCB 776.8M
  • IPO Year
  • FLGT 2016
  • MCB 2017
  • Fundamental
  • Price
  • FLGT $22.51
  • MCB $76.93
  • Analyst Decision
  • FLGT Buy
  • MCB Buy
  • Analyst Count
  • FLGT 3
  • MCB 2
  • Target Price
  • FLGT $25.33
  • MCB $84.50
  • AVG Volume (30 Days)
  • FLGT 218.2K
  • MCB 97.4K
  • Earning Date
  • FLGT 11-07-2025
  • MCB 10-23-2025
  • Dividend Yield
  • FLGT N/A
  • MCB 0.79%
  • EPS Growth
  • FLGT N/A
  • MCB N/A
  • EPS
  • FLGT N/A
  • MCB 6.17
  • Revenue
  • FLGT $303,223,000.00
  • MCB $274,307,000.00
  • Revenue This Year
  • FLGT $15.19
  • MCB $13.56
  • Revenue Next Year
  • FLGT $10.58
  • MCB $11.39
  • P/E Ratio
  • FLGT N/A
  • MCB $12.33
  • Revenue Growth
  • FLGT 4.31
  • MCB 10.33
  • 52 Week Low
  • FLGT $14.57
  • MCB $47.08
  • 52 Week High
  • FLGT $23.57
  • MCB $81.33
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 53.81
  • MCB 49.46
  • Support Level
  • FLGT $22.09
  • MCB $73.74
  • Resistance Level
  • FLGT $23.09
  • MCB $76.45
  • Average True Range (ATR)
  • FLGT 0.65
  • MCB 1.88
  • MACD
  • FLGT -0.09
  • MCB -0.15
  • Stochastic Oscillator
  • FLGT 41.99
  • MCB 54.42

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: